Please login to the form below

Not currently logged in
Email:
Password:

Bioinformatics firm Eagle adds to senior team

Appoints Michael Reynolds and promotes Will Spooner and Glenn Proctor

Eagle has appointed Michael Reynolds as vice president of global sales as it prepares to launch a new bioinformatics software platform that will allow 'intelligent sharing' of genomic data later this year.

Reynolds joins the Cambridge, UK-based company from Pilgrim Software, where he was director of EMEA sales, and during a 20-year pharma and life sciences career his prior roles include stints at Smart Analyst, APC Pharma and Etrials.

Eagle Will SpoonerEagle Glenn Proctor 

Eagle has also promoted two members of its senior team, making Will Spooner (above left) chief scientific officer while Glenn Proctor (above right) becomes chief technical officer.

Spooner, who has previously served at the likes of the Wellcome Trust Sanger Institute and the European Bioinformatics Institute, will be responsible for ensuring that Eagle remains "at the forefront of bioinformatics knowledge", the company said.

Meanwhile, Proctor - who previously led the software development of Ensembl at the European Bioinformatics Institute - will be tasked with managing and improving Eagle's systems to best support customers.

Abel Ureta-Vidal, CEO of Eagle, said: “These appointments are critical to Eagle's ongoing success. Michael brings a wealth of sales and marketing experience, and will be pivotal in further building Eagle's business.

"With the appointments of Will and Glenn to their respective roles, we now have an expert management team which will ensure Eagle's customers are able to receive the maximum benefit from Eagle's comprehensive services.”

5th August 2014

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics